2:03 PM ET
10-Q
Financial Results
60 Degrees Pharmaceuticals Q3 2026 Results: Net Loss of $2.56M, Loss Widens
60 Degrees Pharmaceuticals reported a net loss of $6.9 million for the nine months ended September 30, 2026, compared to $5.9 million in the prior year period. The company's cash position decreased significantly to $306,191, and management expressed concerns regarding its ability to continue as a going concern without additional financing.
- Key figure
- Net loss $2.56M